Obese patients with schizophrenia and schizoaffective disorder: Efficacy of injectable long-acting risperidone

被引：0
|
作者：
Permuy, RT
Turner, MS
Bouhours, P
机构：
[1] Zwolse Poort, Raalte, Netherlands
[2] Larkfield Ctr, Glasgow, Lanark, Scotland
[3] Janssen Cilag, Issy Les Moulineaux, France
来源：
SCHIZOPHRENIA RESEARCH | 2004年 / 67卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder
    Lasser, RA
    Bossie, CA
    Zhu, Y
    Gharabawi, G
    Eerdekens, M
    Davidson, M
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (09) : 898 - 905
  • [2] Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable
    Rosa, Fernanda
    Schreiner, Andreas
    Thomas, Pierre
    Sherif, Tarek
    [J]. CLINICAL DRUG INVESTIGATION, 2012, 32 (04) : 267 - 279
  • [3] The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable
    Gharabawi, Georges
    Bossie, Cynthia
    Turkoz, Ibrahim
    Kujawa, Mary
    Mahmoud, Ramy
    Simpson, George
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 2007, 195 (12) : 976 - 982
  • [4] Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable
    Fernanda Rosa
    Andreas Schreiner
    Pierre Thomas
    Tarek Sherif
    [J]. Clinical Drug Investigation, 2012, 32 : 267 - 279
  • [5] Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder
    Lindenmayer, Jean-Pierre
    Khan, Akbar
    Eerdekens, Marielle
    Van Hove, Ilse
    Kushner, Stuart
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (02) : 138 - 144
  • [6] Efficacy and safety of long-acting injectable risperidone in patients with schizophrenia
    Bouhours, P
    Schreiner, A
    Rendall, MR
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 170 - 171
  • [7] Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder
    Benabarre, A.
    Castro, P.
    Sanchez-Moreno, J.
    Martinez-Aran, A.
    Salamero, M.
    Murru, A.
    Franco, C.
    Vieta, E.
    [J]. ACTAS ESPANOLAS DE PSIQUIATRIA, 2009, 37 (03): : 143 - 147
  • [8] Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder
    Lasser, R
    Bossie, CA
    Gharabawi, G
    Eerdekens, M
    Nasrallah, HA
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2004, 83 (2-3) : 263 - 275
  • [9] Long-acting risperidone in young adults with schizophrenia and schizoaffective disorder
    Lasser, R
    Bossier, C
    Zhu, Y
    Ciliberto, N
    Trinh, B
    Kane, J
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S236 - S236
  • [10] Long-acting risperidone in stable patients with schizoaffective disorder
    Mohl, A
    Westlye, K
    Opjordsmoen, S
    Lex, A
    Schreiner, A
    Benoit, M
    Bräunig, P
    Medori, R
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : 22 - 31
12345